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Background: There is little known about how payer status impacts clinical outcomes in a universal single-
payer system such as the UK National Health Service (NHS). The aim of this study was to evaluate the rela-
tionship between payer status (private or public) and clinical outcomes following cardiac surgery from NHS
providers in England.
Methods: The National Adult Cardiac Surgery Audit (NACSA) registry was interrogated for patients who
underwent adult cardiac surgery in England from 2009 to 2018. Information on socioeconomic status were
provided by linkage with the Iteration of the English Indices of Deprivation (IoD). The primary outcome was
in-hospital mortality. Secondary outcomes included incidence of in-hospital postoperative cerebrovascular
accident (CVA), renal dialysis, sternal wound infection, and re-exploration. To assess whether payer status
was an independent predictor of in-hospital mortality, binomial generalized linear mixed models (GLMM)
were fitted along with 17 items forming the EuroSCORE and the IoD domains.
Findings: The final sample consisted of 280,209 patients who underwent surgery in 31 NHS hospitals in Eng-
land from 2009 to 2018. Of them, 5,967 (2.1%) and 274,242 (97.9%) were private and NHS payers respectively.
Private payer status was associated with a lower risk of in-hospital mortality (OR 0.79; 95%CI 0.65  0.97;
P = 0.026), CVA (OR 0.77; 95%CI 0.60  0.99; P = 0.039), need for re-exploration (OR 0.84; 95%CI 0.72  0.97;
P = 0.017) and with non-significant lower risk of dialysis (OR 0.84; 95%CI 0.69  1.02; P = 0.074). Private
payer status was found to be independently associated with lower risk of in-hospital mortality in the elective
subgroup (OR 0.76; 95%CI 0.61  0.96; P = 0.020) but not in the non-elective subgroup (OR 1.01; 95%CI 0.64 
1.58; P = 0.976).
Interpretation: In conclusion, using a national database, we have found evidence of significant beneficial effect
of payer status on hospital outcomes following cardiac surgery in favour of private payers regardless their
socioeconomic factors.
© 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/)stol BRC).
Benedetto).
Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)1. Introduction
Many healthcare systems distribute resources on the basis of
equitable access to healthcare for people at the same risk [1]. How-
ever, health inequalities arising from the unequal distribution ofsocial, environmental and economic conditions have been recognized
in several clinical settings [2,3]. In particular, the influence of primary
payer status (i.e. private or public) has become a central focus of
modern healthcare system reforms and public scrutiny [2,3].
Acquired heart diseases remain the leading cause of death inWestern
countries [4]. Cardiac surgery constitutes the “gold standard” treat-
ment in many cases and is the most frequently used and costly 'high-
tech' procedures carried out. There is much interest as to whether
primary payer and socioeconomic status affect clinical outcomes
[57]. In the United States, where there is no universal healthcare
Research in context
Evidence before this study
Universal health coverage represents the best way to guarantee
health equity. However, inequalities within the health system
still exist in those countries that have adopted a universal pub-
licly financed health system. In particular, unequal distribution
of social, environment and economic conditions has been rec-
ognized as sources of health inequalities. We searched PubMed
using the following key words: “socio-economic inequality/sta-
tus/disparity”, “primary payer status”, “health inequalities”,
“cardiac surgery/heart surgery”. The literature search showed
that research regarding the association between those factors
and health inequalities in patients with cardiovascular disease
in the UK remains scarce. Moreover, the effect of primary payer
status on outcomes following cardiac surgery in the UK remains
undefined.
Added value of this study
This analysis is based on a large data set comprising nearly a
quarter of a million patients over a 10-year period and uses
unbiased clinical outcomes (all-cause mortality) as primary
outcomes and a standardized measure (the UK Index of Multi-
ple Deprivation) to assess socioeconomic deprivation. The
added value of this study is that in the UK, private payer status
is associated with a lower risk of mortality and major complica-
tions in patients undergoing heart surgery with NHS providers.
In particular, private payer status was associated with a risk
reduction in mortality after controlling for case mix, variables
related to the surgical procedures and neighbourhood socioeco-
nomic status. The disadvantage for NHS payer status was more
marked in elective patients, for those undergoing isolated
CABG surgery and for those with most deprived neighbourhood
socioeconomic status.
Implications of all the available evidence
The results of this study suggest that a complex interaction
between socioeconomic and health systemrelated factors for
patients undergoing cardiac surgery exists and further research
is required to identify interventions to reduce health inequal-
ities. Patients from the most deprived areas are more vulnera-
ble but also more susceptible to the beneficial effect of
preventive interventions which can ultimately reduce resource
utilization. Finally, primary payer and socioeconomic status
should be strongly considered during preoperative patient risk
stratification in an effort to improve postoperative outcomes.
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grams (i.e., Medicaid and Medicare) have been shown to have worse
clinical outcomes compared with privately insured patients. This
occurs in multiple clinical settings, including cardiac surgery [2,57].
There is little known about how payer status impacts clinical out-
comes in a universal single-payer system (also known as universal
health coverage) such as the UK National Health Service (NHS) 
financed entirely by the government through taxation. A small pro-
portion of patients voluntarily subscribe to additional health insur-
ance and have the option to access services privately provided by
both public and private hospitals [8,9]. The outcomes of patients who
pay for private healthcare within the NHS are of interest because
they are treated by the same clinical teams as those who receive care
funded by the government. Private payment allows the patients to
access their surgery at a time of their choosing, with a surgeon oftheir choosing and access “cinderella” services such as single-rooms
and enhanced menus. Therefore, understanding the outcomes of
these patients could highlight complex socioeconomic and health-
system related factors that might be targeted to improve clinical out-
comes in patients undergoing cardiac surgery. The aim of this study
was to evaluate the relationship between payer status (private or
public) and clinical outcomes following cardiac surgery from NHS
providers in the UK.2. Methods
The study was approved by Health Research Authority (HRA) and
Health and Care Research Wales (HCRW) (IRAS ID: 278,171).
2.1. Data and data management
The National Institute for Cardiovascular Outcomes Research
(NICOR) National Adult Cardiac Surgery Audit (NACSA) registry was
interrogated for patients who underwent adult cardiac surgery in
England from 2009 to 2018. This registry prospectively collects
demographic, as well as pre-, peri- and post-operative clinical infor-
mation and mortality information for all major adult cardiac surgery
procedures performed in England and its key function is benchmark-
ing surgical practice. The risk model currently used to adjust for case-
mix is the European System for Cardiac Operative Risk Evaluation
(EuroSCORE) [10]. EuroSCORE is an operative mortality risk predic-
tion model which takes into account 17 covariates encompassing
patient-related, cardiac and operation-related characteristics.
Reproducible algorithms were applied to the database in order to
clean the data [11]. There were 298,743 adult patients in the database
reported as undergoing cardiac surgery in England from 2008 to
2019. Patients missing information on socioeconomic status
(n = 12,947 patients) were excluded. We further excluded 5548
patients whose operation was carried out in exclusively private insti-
tutions (6 hospitals). Patients undergoing cardiac surgery in private
hospitals in the England are highly selected and patients who present
with complications postoperatively are commonly transferred to
NHS hospitals, therefore making hospital outcomes difficult to inter-
pret. Information on socioeconomic status were provided by linkage
with the Iteration of the English Indices of Deprivation (IoD) [12].
Indices of Deprivation are the England Governments official measure
of relative deprivation at a small local area level (Lower-layer Super
Output Areas  equivalent to a neighbourhood) across England. The
iteration is based on seven different domains of deprivation: Income
Deprivation, Employment Deprivation, Education, Skills and Training
Deprivation, Health Deprivation and Disability, Crime, Barriers to
Housing and Services, Living Environment Deprivation. Combining
information from the seven domains can be used to produces an
overall relative measure of deprivation: The Index of Multiple Depri-
vation (IMD). The weight for each domain is derived from consider-
ation of the academic literature on poverty and deprivation, as well
as the levels of robustness of the indicators. The IoD ranks every
neighbourhood in England from 1 (most deprived area) to 32,844
(least deprived area). Deciles are calculated by ranking the 32,844
neighbourhoods in England from most deprived to least deprived
and dividing them into 10 equal groups.2.2. Outcomes variables
The primary outcome was in-hospital mortality. Missing or con-
flicting data for in-hospital mortality were obtained via record link-
age to the Office for National Statistics census database. Secondary
outcomes included incidence of in-hospital postoperative cerebro-
vascular accident (CVA), renal dialysis, sternal wound infection, and
re-exploration.
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Categorical variables were summarized as counts and percen-
tages. Continuous variables were summarized as median (interquar-
tile range) or mean (SD). Baseline characteristics between the two
groups were compared using standardized mean difference (SMD)
and a value >0.2 was considered as indicative of meaningful imbal-
ance. Standardization was based on the generalized linear mixed
models (GLMM) analysis. To assess whether payer status (private or
NHS) was an independent predictor of in-hospital mortality, binomial
GLMMs were fitted. The 17 items forming the EuroSCORE and the
seven IoD domains were included as fixed terms in the regression
model. Outcomes were analysed separately using separate models. A
clustering effect was anticipated for patients operated in the same
hospital or by the same surgeon and therefore these two variables
were included in the model as random intercepts. As surgical out-
comes may have improved in the last decade, year of surgery was
also included as random intercept. Random effects were reported as
variance. One feature of the mixed effects model is that the variance
of the random effect is directly interpretable. The marginal R-squared
considers only the variance of the fixed effects, while the conditional
R-squared takes both the fixed and random effects into account [13].
Three subgroup analyses were performed for the main outcome
(mortality) to identify possible effect modifiers: (1) elective-vs non-
elective (by excluding or limiting the analysis to patients with emer-
gency surgery, unstable angina, acute endocarditis, critical preopera-
tive state and ischaemic ventricular septal defect); (2) isolatedFig. 1. Bar plot with total number of NHS and pcoronary artery bypass grafting (CABG) procedures vs other than iso-
lated CABG surgery; (3) least vs most deprived neighbourhood socio-
economic status (defined as IMD 5 vs IMD>5). We also tested the
interaction between IMD decile and payer status in a fully mixed
adjusted model checking for non-linearity by comparing a linear vs a
natural spline term (3 knots). Effect estimates for fixed terms were
reported as Odds ratio (OR) and relative 95% confidence. P-value
<0.05 was considered significant in all the analysis. All analyses
were performed in R version 4.0.0. lme4, lmerTest, sjPlot packages
were used to fit and present GLMM results.
2.4. Role of funding source
The funder of the study had no role in study design, data collec-
tion, data analysis, data interpretation, or writing of the report. UB
had full access to all the data in the study and UB, AD, BG, SS, MP, DF,
LC, AB, SO, MC, GC, TD, EA, GDA had final responsibility for the deci-
sion to submit for publication.
3. Results
The final sample consisted of 280,209 patients who underwent
surgery in 31 NHS hospitals in England from 2009 to 2018. Of them,
5967 (2.1%) and 274,242 (97.9%) were private and NHS payers,
respectively. The proportion of private payers ranged from 1.6% in
2013 to 2.8% in 2009 across years (Fig. 1) and from 0% to 7% across
different hospitals (Supplementary Table 1). Patient characteristicsrivate payers per year from 2009 to 2018.
Table 1
Patients characteristic and neighbourhood socioeconomic status in the National Adult Cardiac Surgery Audit registry in the 20092018 cohort (England).
NHS payers Private payers SMD
Number of patients 274,242 5967
EuroSCORE risk factors
Age (mean (SD)) 67.07 (11.77) 66.13 (11.30) 0.081
Female, n (%) 75,447 (27.5) 1286 (21.6) 0.139
Neurological dysfunction, n (%) 9986 (3.6) 126 (2.1) 0.092
Creatinine>200 mmol/l, n (%) 5728 (2.1) 44 (0.7) 0.115
Recent MI, n (%) 53,913 (19.7) 494 (8.3) 0.333
Critical preoperative state, n (%) 8691 (3.2) 71 (1.2) 0.136
Unstable angina, n (%) 12,458 (4.5) 111 (1.9) 0.153
Moderate LVEF, n (%) 60,461 (22.0) 1018 (17.1) 0.126
Poor LVEF, n (%) 13,732 (5.0) 209 (3.5) 0.075
Previous cardiac surgery, n (%) 13,553 (4.9) 361 (6.0) 0.049
Chronic pulmonary disease, n (%) 30,574 (11.1) 416 (7.0) 0.146
Extracardiac arteriopathy, n (%) 29,159 (10.6) 412 (6.9) 0.132
Pulmonary hypertension, n (%) 45,230 (16.5) 1055 (17.7) 0.032
Emergency, n (%) 10,648 (3.9) 88 (1.5) 0.150
Active endocarditis, n (%) 5448 (2.0) 66 (1.1) 0.071
Surgery on thoracic aorta, n (%) 17,408 (6.3) 403 (6.8) 0.016
Other than isolated CABG, n (%) 126,765 (46.2) 3139 (52.6) 0.128
Post infarct septal rupture, n (%) 599 (0.2) 2 (0.0) 0.052
Indices of Deprivation (IoD)
Barriers to Housing and Services Decile (mean (SD)) 5.63 (2.90) 4.97 (2.94) 0.224
Crime Decile (mean (SD)) 5.77 (2.87) 7.05 (2.52) 0.476
Education and Skills Decile (mean (SD)) 5.55 (2.82) 7.35 (2.37) 0.687
Employment Decile (mean (SD)) 5.52 (2.82) 7.30 (2.35) 0.686
Health and Disability Decile (mean (SD)) 5.56 (2.86) 7.39 (2.40) 0.695
Income Decile (mean (SD)) 5.62 (2.82) 7.41 (2.28) 0.698
Living Environment Decile (mean (SD)) 5.65 (2.86) 5.73 (2.86) 0.027
In-hospital outcomes P-value
Mortality, n (%) 7882 (2.9) 104 (1.7) <0.001
CVA, n (%) 4326 (1.8) 68 (1.3) 0.007
SWI, n (%) 1473 (1.0) 17 (0.5) 0.016
Dialysis, n (%) 8033 (3.2) 111 (2.0) <0.001
Re-exploration, n (%) 11,027 (4.4) 199 (3.5) 0.001
CABG coronary artery bypass grafting; CVA cerebrovascular accidents; SWI sternal wound infection; LVEF left ventricular ejection fraction; MI myocardial infarction;
NHS national health system; SMD standardized mean difference.
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showed a tendency towards a lower risk profile including a lower
incidence of recent myocardial infarction. When compared to NHS
payers, private payers were associated with less deprived neighbour-
hood socioeconomic status (Fig. 2). When compared to NHS payers,
private payers showed a lower incidence of in-hospital complicationsFig. 2. Dot plot with incidence of individual complications (re-exploration, mortality, cerebr
and private payers (blue line) per year. (For interpretation of the references to color in this figincluding mortality (1.7%. vs. 2.9%; P<0.001), cerebrovascular acci-
dent (1.3% vs. 1.8%, P = 0.007), surgical wound infection (0.5% vs 1.0%;
P = 0.016), need for postoperative dialysis (2.0% vs 3.2%; P<0.001)
and re-exploration (3.5% vs. 4.4%; P<0.001). This trend was consistent
through the study period (Fig. 3). Table 2 summarizes multilevel,
multivariable adjusted GLMM results. We then adjusted the effect ofovascular accidents [CVA], dialysis and sternal wound infection [SWI]) in NHS (red line)
ure legend, the reader is referred to the web version of this article.)
Fig. 3. Distribution of Index of Multiple Deprivation (IMD) in NHS and private payers.
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dures and neighbourhood socioeconomic status: private payer status
was associated with a lower risk of in-hospital mortality (OR 0.79;
95%CI 0.65  0.97;P = 0.026), CVA (OR 0.77; 95%CI 0.60  0.99;
P = 0.039), need for re-exploration (OR 0.84; 95%CI 0.72  0.97;
P = 0.017) and with non-significant lower risk of dialysis (OR 0.84;
95%CI 0.69  1.02; P = 0.074). We found a more remarkable clustering
effect related to individual surgeons (15% of surgeons associated with
45% relative risk increase of mortality) and individual hospitals (15% of
hospital associated with 19% relative risk increase of mortality). When
the analysis was stratified for elective vs non-elective subgroups, pri-
vate payer status was found to be independently associated with lower
risk of in-hospital mortality in the elective subgroup (OR 0.76; 95%CI
0.61  0.96; P = 0.020) but not in the non-elective subgroup (OR 1.01;
95%CI 0.64  1.58; P = 0.976) (Supplementary Table 2). When com-
pared to NHS payer status, private payer status was independently
associated with a lower risk of mortality in patients undergoing iso-
lated CABG surgery OR (0.63; 95%CI 0.41  0.96; P = 0.033) while this
trend was not significant for patients undergoing other than isolated
CABG surgery (OR 0.86; 95%CI 0.68  1.08; P = 0.201) (Supplementary
Table 3). Finally, the association between private payer status and
lower risk of mortality was more marked in the least deprived patients
(OR 0.42; 95%CI 0.24  0.74; P = 0.002) than in patients with most
deprived neighbourhood socioeconomic status (OR 0.90; 95%CI 0.73 
1.13; P = 0.370) (Supplementary Table 4). We found a significant asso-
ciation between payer status and IMD deciles (P = 0.04) with the larg-
est difference in mortality between private and NHS payer at the
lowest IMD deciles (Fig. 4).
4. Discussion
The main finding of the study was that in the UK, private payer
status was associated with a lower risk of mortality and major com-
plications in patients undergoing heart surgery with NHS providers.
The primary analysis showed that private payer status was associated
with 21% relative risk reduction in mortality after controlling for case
mix, variables related to the surgical procedures and neighbourhood
socioeconomic status. The disadvantage for NHS payer status was
more marked in elective patients, for those undergoing isolatedCABG surgery and for those with most deprived neighbourhood
socioeconomic status.
Universal health coverage is a major health and political concern
worldwide and has been described as the best way to achieve health
equity. Recently, several countries have successfully switched to a
publicly financed health system [4]. However, health inequalities
persist even in countries with a publicly financed system, such as
the UK. Wealth disparities and other social determinants are recog-
nized causes of health inequalities, but health care-related factors
may also have a role [8,9]. Overall, research regarding the associa-
tion between health-care related factors and health inequalities in
patients with cardiovascular disease in the UK remains scarce. Previ-
ous studies have suggested that an adverse association between
increasing social deprivation and outcomes following cardiac sur-
gery or heart transplant [57,14,15]. However, these studies did not
distinguish between effects due to payer status and effects due to
socioeconomic deprivation. Because payer status and socioeconomic
status tend to be highly correlated, this represents an important
confounding factor.
Previously, the effect of payer status on outcomes following car-
diac surgery in the UK remained undefined. We used a standardized
measure of socioeconomic deprivation to adjust the effect of payer
status but also a large number of other patient factors that cluster
within socioeconomic status. We found evidence that private payer
status was associated with increased survival and reduced incidence
of complications. This association has a presumptive multi-factorial
origin. An initial consideration is that NHS payers tended to present
with a higher burden of comorbidities and more commonly under-
went non-elective operations. For instance, NHS payers were more
likely to undergo surgery in the context of a recent myocardial infarc-
tion. This might be related to the fact that private payers commonly
access to the healthcare system at an earlier stage when compared to
NHS payers. However, this observation also supports the hypothesis
that private payers may be given priority on the waiting list over
NHS payers. However, after adjusting for confounders including base-
line clinical characteristics, payer status differences remained signifi-
cant thus supporting a causal mechanism between health financing
and clinical outcomes. Interestingly, the advantage from private
payer status was significant amongst elective patients and those
undergoing isolated CABG surgery. This observation could be
explained by the fact that outcomes in high-risk setting are predomi-
nantly determined by the clinical presentations, while complex inter-
action between socioeconomic and health care-related factors may
be relevant for patients at low risk. Second, the observed findings
may be influenced by the bias amongst healthcare providers. For
selected procedures, expert consultation at centers with higher oper-
ative volumes has been shown to improve postoperative outcomes.
Private payers are likely referred to these high-volume centers while
NHS payers may have little input in the selection of a surgeon. More-
over, primary care diagnostic patterns may differ as a function of
payer status. However, this analysis adjusted for the clustering effect
related to individual surgeons and hospital and the association
between payer status and outcomes remained significant. It should
also be considered that private payers are operated on only by the
responsible consultant surgeon and anaesthetist and they are not
considered for training sessions. However, previous studies did not
show any association between cases performed by trainees and
increased risk of hospital mortality [16].
Remarkably, the advantage from private payer status was more
relevant in patients with most deprived neighbourhood socioeco-
nomic status after adjustment for case mix, procedure specific varia-
bles and clustering effect related to surgeons and hospitals, while
this association was no longer significant in patients with least
deprived neighbourhood socioeconomic status. We can speculate
that patients with most deprived neighbourhood socioeconomic sta-
tus are more likely to be exposed to communication failures and
Table 2
Results of generalized linear mixed model (binomial) for outcomes of interest.
Mortality CVA Dialysis SWI Re-exploration
Predictors Odds Ratios CI p Odds Ratios CI p Odds Ratios CI p Odds Ratios CI P Odds Ratios CI p
(Intercept) 0.00 0.00  0.00 <0.001 0.00 0.00  0.00 <0.001 0.00 0.00  0.00 <0.001 0.00 0.00  0.01 <0.001 0.01 0.01  0.01 <0.001
Age 1.04 1.04  1.05 <0.001 1.03 1.03  1.03 <0.001 1.03 1.03  1.04 <0.001 1.01 1.01  1.02 <0.001 1.02 1.01  1.02 <0.001
Female 1.44 1.36  1.51 <0.001 1.05 0.98  1.12 0.175 1.12 1.06  1.18 <0.001 1.06 0.94  1.19 0.344 0.78 0.74  0.81 <0.001
Neurological dysfunction 1.28 1.16  1.41 <0.001 1.75 1.56  1.97 <0.001 1.14 1.03  1.27 0.011 1.17 0.92  1.48 0.197 1.13 1.03  1.25 0.008
Creatinine>200 mmol/l 2.72 2.47  3.00 <0.001 1.33 1.13  1.57 0.001 7.26 6.69  7.87 <0.001 1.74 1.32  2.30 <0.001 1.74 1.57  1.92 <0.001
Recent MI 1.42 1.33  1.51 <0.001 1.06 0.96  1.17 0.222 1.42 1.33  1.52 <0.001 1.43 1.25  1.63 <0.001 1.51 1.43  1.59 <0.001
Critical preoperative state 2.11 1.94  2.31 <0.001 1.26 1.09  1.45 0.002 1.99 1.82  2.18 <0.001 1.07 0.83  1.38 0.593 1.34 1.22  1.48 <0.001
Unstable angina 1.20 1.10  1.32 <0.001 1.06 0.92  1.22 0.436 1.17 1.06  1.28 0.001 1.35 1.06  1.72 0.014 1.13 1.04  1.23 0.006
Moderate LVEF 1.55 1.47  1.64 <0.001 1.17 1.09  1.26 <0.001 1.48 1.40  1.56 <0.001 1.26 1.11  1.42 <0.001 1.08 1.03  1.14 0.001
Poor LVEF 2.99 2.77  3.23 <0.001 1.11 0.97  1.28 0.134 2.15 1.98  2.34 <0.001 1.38 1.12  1.71 0.003 1.20 1.10  1.30 <0.001
Previous cardiac surgery 3.09 2.88  3.32 <0.001 1.59 1.43  1.77 <0.001 2.02 1.86  2.18 <0.001 1.52 1.22  1.90 <0.001 1.20 1.11  1.30 <0.001
Chronic pulmonary disease 1.42 1.34  1.52 <0.001 1.13 1.03  1.24 0.008 1.37 1.28  1.46 <0.001 1.75 1.53  2.02 <0.001 0.95 0.89  1.01 0.083
Extracardiac arteriopathy 1.76 1.65  1.87 <0.001 1.66 1.53  1.80 <0.001 1.51 1.42  1.61 <0.001 1.28 1.10  1.49 0.001 1.04 0.98  1.10 0.224
Pulmonary hypertension 1.44 1.35  1.53 <0.001 1.05 0.96  1.15 0.284 1.47 1.38  1.57 <0.001 1.18 1.01  1.36 0.032 1.11 1.05  1.18 <0.001
Emergency 4.93 4.58  5.31 <0.001 2.99 2.69  3.33 <0.001 2.85 2.62  3.10 <0.001 1.17 0.90  1.52 0.248 1.57 1.44  1.71 <0.001
Active endocarditis 1.73 1.55  1.93 <0.001 1.22 1.04  1.43 0.015 1.69 1.51  1.89 <0.001 1.01 0.70  1.45 0.975 1.49 1.33  1.66 <0.001
Surgery on thoracic aorta 2.38 2.20  2.57 <0.001 2.70 2.46  2.97 <0.001 1.87 1.72  2.03 <0.001 1.09 0.86  1.38 0.475 1.58 1.47  1.69 <0.001
Other than isolated CABG 1.76 1.66  1.87 <0.001 1.83 1.70  1.98 <0.001 1.80 1.70  1.91 <0.001 0.95 0.84  1.08 0.478 2.00 1.91  2.10 <0.001
Post-infarct septal rupture 4.31 3.49  5.33 <0.001 1.08 0.65  1.81 0.767 3.01 2.36  3.84 <0.001 0.50 0.16  1.59 0.239 1.44 1.07  1.94 0.017
Private Vs NHS 0.79 0.65  0.97 0.026 0.77 0.60  0.99 0.039 0.84 0.69  1.02 0.074 0.73 0.46  1.18 0.203 0.84 0.72  0.97 0.017
Barriers to Housing and Services 1.00 0.99  1.01 0.369 0.99 0.98  1.00 0.128 0.99 0.98  1.00 0.176 1.00 0.98  1.02 0.983 1.00 0.99  1.00 0.338
Crime 0.98 0.97  1.00 0.011 1.00 0.98  1.01 0.783 1.00 0.99  1.01 0.660 0.99 0.97  1.02 0.670 1.00 0.99  1.01 0.825
Education and Skills 1.01 1.00  1.03 0.078 1.01 0.99  1.03 0.209 1.00 0.98  1.02 0.935 1.03 0.99  1.07 0.124 1.02 1.01  1.03 0.005
Employment 1.05 1.02  1.08 0.002 1.02 0.98  1.06 0.337 1.05 1.02  1.08 0.001 1.02 0.95  1.08 0.650 1.02 1.00  1.05 0.045
Health and Disability 0.98 0.96  1.00 0.018 1.00 0.97  1.02 0.770 0.98 0.96  1.00 0.025 0.99 0.94  1.03 0.505 0.99 0.97  1.00 0.141
Income 0.95 0.93  0.98 0.001 0.96 0.93  1.00 0.043 0.95 0.93  0.98 0.001 0.96 0.90  1.02 0.180 0.97 0.94  0.99 0.004
Living Environment 1.01 1.00  1.02 0.012 1.01 1.00  1.02 0.231 1.01 1.00  1.02 0.104 1.00 0.98  1.02 0.848 1.00 0.99  1.01 0.729
Random Effects
s2 3.29 3.29 3.29 3.29 3.29
t00 0.14 Consultant 0.12 Consultant 0.19 Consultant 0.49 Consultant 0.34 Consultant
0.03 hospital 0.88 hospital 0.64 hospital 4.11 hospital 0.15 hospital
0.01 year 0.00 year 0.03 year 0.05 year 0.03 year
ICC 0.05 0.23 0.21 0.59 0.14
N 649 Consultant 633 Consultant 628 Consultant 523 Consultant 636 Consultant
31 hospital 31 hospital 31 hospital 30 hospital 31 hospital
10 year 10 year 10 year 10 year 10 year
Observations 280,117 248,741 254,846 152,748 257,041
Marginal R2 / Conditional R2 0.228 / 0.270 0.100 / 0.309 0.147 / 0.322 0.020 / 0.594 0.058 / 0.188
CABG coronary artery bypass grafting; CVA cerebrovascular accidents; ICC interclass correlation coefficient; LVEF left ventricular ejection fraction; MI myocardial infarction; NHS national health system; SMD standardized mean difference;












Fig. 4. Interaction between payer status and Index of Multiple Deprivation (IMD).
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health outcomes. In this scenario, private payer status could coun-
teract these barriers by promoting early access to healthcare system
and by facilitating continuity of care which can ultimately result
into improved clinical outcomes. Our results are supported by other
reports based on outcomes from private healthcare systems, such as
in the US. Recent efforts to examine the impact of primary payer
and insurance status within surgical populations have focused on
specific patient populations and surgical subspecialties and type of
insurance was found to predict disease severity at the time of treat-
ment [17,18].
4.1. Strength and limitations
The key strength of this study is that the analysis has been based
on a large data set comprising nearly a quarter of a million patients
over a 10-year period. It used unbiased clinical outcomes (all-cause
mortality) as primary outcomes and a standardized measure (UK
IMD) to assess socioeconomic deprivation. However, cause of death
was not recorded in the NACSA database, meaning it is not possible
to comment on mode of death and how this may have been influ-
enced by payer status and socioeconomic deprivation. Notably, there
was a large imbalance of group sizes and some hospitals had no pri-
vate payers which may have affected estimates prediction.
We were also unable to distinguish between insured and self-
funded private payers, although we believe that the last group should
represent a very minority of patients. Also, it is possible that the ability
to pay is simply a much more accurate indicator of personal socioeco-
nomic status than area-based measures, and that therefore the effect
captured in the analysis is still due to a more general effect of socioeco-
nomic status. Regarding, the difference of the effect of payer status on
elective vs non-elective patients, this could be due to the fact that sur-
geons could be more likely to perform elective high-risk surgery in pri-
vate payers and therefore the magnitude of advantage from private
payer status was actually larger than the one observed. Finally, the rela-
tive lack of confounding by the covariates does not truly establish a
causal relationship between payer status and outcome.
Conclusions
In conclusion, using a national database, we have found evidence
of significant beneficial effect of payer status on hospital outcomes
following cardiac surgery in favour of private payers regardless
their socioeconomic factors. These results suggest that a complexinteraction between socioeconomic and health systemrelated fac-
tors for patients undergoing cardiac surgery exists and further inves-
tigations are required to identify interventions which can reduce
health inequalities. Patients from the most deprived areas are more
vulnerable but also more susceptible to the beneficial effect of
preventive interventions which can ultimately reduce resource
utilization.
Although many of the strategies to tackle health inequalities lie
outside the boundaries of healthcare services, healthcare organiza-
tions have significant opportunities to do far more to reduce inequal-
ities in health. Strategies focusing on improving health equity may
differ from those focusing only on the improvement of the average
population health, as they are responsive only to the neediest ones
and those with the highest risks of inequality. For instance, current
benchmarking of cardiac units in UK could be stratified by socioeco-
nomic status.
Finally, these results suggest, that primary payer and socioeconomic
status should be strongly considered during preoperative patient risk
stratification in an effort to improve postoperative outcomes.
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